Global Drug Infusion Systems Market: Focus on Products, Application, Competitive Landscape and 57 Countries - Analysis and Forecast (2017-2025)
Hard copy option is available on any of the options above at an additional charge of $500. Please email us at [email protected] with your request.
The increased prevalence of chronic diseases and the rising geriatric population has led to the high demand for better medicines and facilities. For the continued and improved care of the patients, the drug infusion systems are being extensively used in the hospitals as well as the home care settings.
As per the Arthritis Foundation, the older population in the U.S. affected by arthritis is estimated to grow to 21% by 2040, from the current value of 15%. The rising prevalence of chronic diseases is another factor contributing to the growth of the market. In the recent years, the prevalence of chronic diseases has been increasing irrespective of the age. As per the World Health Organization (WHO), the global prevalence of diabetes increased to 8.5% in adults over the age of 18 years in 2014 from 4.7% in 1980. The prevalence of genetic diseases, and cancer has also witnessed a rise in the recent years.
As per the U.S. FDA an infusion pump is a medical device that delivers controlled amounts of fluids such as nutrients and medication.
The drug infusion systems market includes various infusion systems products including the components such as pumps, accessories and disposables. The market includes several products such as large volume pumps, enteral pumps, syringe pumps, insulin pumps, elastomeric pumps, Patient controlled Analgesia (PCA), ambulatory pumps, and implantable pumps, among many others. These devices are being used for the administration of fluids and medication to a number of diseases, and therapeutic areas such as diabetes, analgesia, nutrition, haematology, oncology and paediatrics. The market analysis includes an in-depth examination of the key ecosystem players, and the key strategies and developments taking place in this market. Additionally, it includes market dynamics (market drivers, opportunities, and challenges), and industry analysis.
The purpose of the study is to gain a holistic view of the drug infusion systems market in terms of various factors influencing it such as recent trends, technological advancements, and regulatory aspects of the market. The scope of this report is centred upon conducting a detailed study of the solutions allied with the drug infusion systems market. The market has been segmented into ‘product’, ‘application’, ‘end users’ and ‘geographical regions’. The report presents the reader with an opportunity to unlock comprehensive insights with respect to the market, and helps in forming well informed strategic decisions. The research uncovers some of the substantial parameters that must be taken into the consideration before entering the market.
This research report aims at answering various aspects of the global market with the help of the key factors driving the market, threats that can possibly inhibit the overall market growth, and the current growth opportunities that are going to shape the future trajectory of the market expansion. The study considers the growth-share matrix model for a comprehensive study of the global drug infusion systems market, and assesses the factors governing the same.
The answers to the following key questions can be derived from this report:
The increased prevalence of chronic diseases and the rising geriatric population has led to the high demand for better medicines and facilities. For the continued and improved care of the patients, the drug infusion systems are being extensively used in the hospitals as well as the home care settings.
As per the Arthritis Foundation, the older population in the U.S. affected by arthritis is estimated to grow to 21% by 2040, from the current value of 15%. The rising prevalence of chronic diseases is another factor contributing to the growth of the market. In the recent years, the prevalence of chronic diseases has been increasing irrespective of the age. As per the World Health Organization (WHO), the global prevalence of diabetes increased to 8.5% in adults over the age of 18 years in 2014 from 4.7% in 1980. The prevalence of genetic diseases, and cancer has also witnessed a rise in the recent years.
As per the U.S. FDA an infusion pump is a medical device that delivers controlled amounts of fluids such as nutrients and medication.
The drug infusion systems market includes various infusion systems products including the components such as pumps, accessories and disposables. The market includes several products such as large volume pumps, enteral pumps, syringe pumps, insulin pumps, elastomeric pumps, Patient controlled Analgesia (PCA), ambulatory pumps, and implantable pumps, among many others. These devices are being used for the administration of fluids and medication to a number of diseases, and therapeutic areas such as diabetes, analgesia, nutrition, haematology, oncology and paediatrics. The market analysis includes an in-depth examination of the key ecosystem players, and the key strategies and developments taking place in this market. Additionally, it includes market dynamics (market drivers, opportunities, and challenges), and industry analysis.
The purpose of the study is to gain a holistic view of the drug infusion systems market in terms of various factors influencing it such as recent trends, technological advancements, and regulatory aspects of the market. The scope of this report is centred upon conducting a detailed study of the solutions allied with the drug infusion systems market. The market has been segmented into ‘product’, ‘application’, ‘end users’ and ‘geographical regions’. The report presents the reader with an opportunity to unlock comprehensive insights with respect to the market, and helps in forming well informed strategic decisions. The research uncovers some of the substantial parameters that must be taken into the consideration before entering the market.
This research report aims at answering various aspects of the global market with the help of the key factors driving the market, threats that can possibly inhibit the overall market growth, and the current growth opportunities that are going to shape the future trajectory of the market expansion. The study considers the growth-share matrix model for a comprehensive study of the global drug infusion systems market, and assesses the factors governing the same.
The answers to the following key questions can be derived from this report:
- What are the major market drivers, challenges, and opportunities in the global drug infusion systems market?
- How did the drug infusion systems market evolve, and what is its scope in the future?
- What is the market share of the leading segments, and sub-segments of the global drug infusion systems market in the period 2016-2025?
- How will each segment of the global drug infusion systems market grow during the forecast period, and what will be the revenue generated by each of the segments by the end of 2025?
- What are the influencing factors that may affect the market share of the key players?
- What are the key developmental strategies implemented by the key players to stand out in this market?
- What is the infusion systems market value in different countries of the world?
- What will be the growth rate of the insulin infusion systems during the forecast period?
- Which product segment is expected to register the highest CAGR for the drug infusion systems market?
- How has the market been segmented on the basis of application? Which application segment has the largest share, and growth rate in the drug infusion systems market?
- How the homecare segment among the end users will grow in the period 2016-2025?
- Which geographical region will contribute to the highest sales of drug infusion systems?
EXECUTIVE SUMMARY
1 MARKET OVERVIEW
1.1. Introduction
1.2. Definition and Characterization
1.3. Infusion Systems Application
1.4. Market Size and Growth Potential
1.5. Technology Advancements
1.6. Pricing Analysis
1.7. Recent Product Launches
2 MARKET DYNAMICS
2.1. Market Drivers
2.2. Market Challenges
2.3. Market Opportunities
3 INDUSTRY INSIGHTS
3.1. Regulatory Scenario
3.2. Patent Landscape
4 COMPETITIVE LANDSCAPE
4.1. Share of Different Strategies
4.2. Porter's Five Force Analysis
4.3. Market Share Analysis
5 GLOBAL DRUG INFUSION SYSTEMS MARKET, BY PRODUCT
5.1. Introduction & Different Components of a Drug Infusion System
5.2. Market Segment
5.3. Large Volume Infusion Systems
5.4. Patient Controlled Analgesia
5.5. Elastomeric Infusion Pumps
5.6. Insulin Infusion Pumps
5.7. Syringe Infusion Systems
5.8. Implantable Infusion Systems
5.9. Ambulatory Infusion Systems
5.10. Enteral Infusion Systems
6 GLOBAL DRUG INFUSION SYSTEMS MARKET, BY APPLICATION
6.1. Introduction
6.2. Oncology/Chemotherapy
6.3. Diabetes
6.4. Analgesia
6.5. Nutrition
6.6. Haematology
6.7. Paediatrics
6.8. Other Applications
7 GLOBAL DRUG INFUSION SYSTEMS MARKET, BY END USER
7.1. Introduction
7.2. Different Types of End Users
8 GLOBAL DRUG INFUSION SYSTEMS MARKET, BY REGION
8.1. Introduction
8.2. North America
8.2.1. The U.S.
8.2.2. Canada
8.3. Europe
8.3.1. Austria
8.3.2. Belarus
8.3.3. Belgium
8.3.4. Denmark
8.3.5. Finland
8.3.6. France
8.3.7. Germany
8.3.8. Greece
8.3.9. Hungary
8.3.10. Ireland
8.3.11. Italy
8.3.12. Luxembourg
8.3.13. Netherlands
8.3.14 Norway
8.3.15. Poland
8.3.16. Portugal
8.3.17. Russia
8.3.18. Spain
8.3.19. Sweden
8.3.20 Switzerland
8.3.21. Turkey
8.3.22. Ukraine
8.3.23. The U.K.
8.4. Asia Pacific
8.4.1. Australia
8.4.2. Bangladesh
8.4.3. China
8.4.4. Hong Kong
8.4.5. India
8.4.6. Indonesia
8.4.7. Japan
8.4.8. South Korea
8.4.9. Malaysia
8.4.10. New Zealand
8.4.11. Pakistan
8.4.12. Philippines
8.4.13. Singapore
8.4.14. Taiwan
8.4.15. Thailand
8.4.16. Vietnam
8.5. Latin America & Middle East & Africa
8.5.1. Argentina
8.5.2. Brazil
8.5.3. Chile
8.5.4. Colombia
8.5.5. Mexico
8.5.6. Egypt
8.5.7. Iran
8.5.8. Israel
8.5.9. Kenya
8.5.10. Kuwait
8.5.11. Nigeria
8.5.12. Oman
8.5.13. Qatar
8.5.14. Saudi Arabia
8.5.15. South Africa
8.5.16. United Arab Emirates
9 COMPANY PROFILES
9.1. Acromed AG
9.1.1. Overview
9.1.2. Acromed AG: Corporate Summary
9.1.3. Acromed AG: Product Portfolio
9.1.4. Acromed AG: SWOT Analysis
9.2. B. Braun Melsungen AG
9.2.1. Overview
9.2.2. B. Braun Melsungen AG: Overall Product Portfolio
9.2.3. Financials
9.2.3.1. Financial Summary
9.2.4. Global Presence
9.2.5. Recent Developments
9.2.6. B.Braun Melsungen AG: SWOT Analysis
9.3. Baxter International Inc.
9.3.1. Overview
9.3.2. Baxter International Inc.: Product Portfolio
9.3.3. Financials
9.3.3.1 Financial Summary
9.3.4. Global Presence
9.3.5. Recent Developments
9.3.6. Baxter International Inc.: SWOT Analysis
9.4. Becton, Dickinson and Company
9.4.1. Overview
9.4.2. Becton, Dickinson and Company: Product Portfolio
9.4.3. Financials
9.4.3.1 Financial Summary
9.4.4. Global Presence
9.4.5. Recent Development
9.4.6. Becton, Dickinson and Company: SWOT Analysis
9.5. Caesarea Medical Electronics Ltd.
9.5.1. Overview
9.5.2. Corporate Summary
9.5.3. Caesarea Medical Electronics Ltd.: Product Portfolio
9.5.4. Caesarea Medical Electronics: SWOT Analysis
9.6. Debiotech S.A.
9.6.1. Overview
9.6.2 Corporate Summary & Product Portfolio
9.6.3. Debiotech S.A.: SWOT Analysis
9.7. Flowonix Medical Inc.
9.7.1. Overview
9.7.2. Corporate Summary & Product Portfolio
9.7.3. Recent Developments
9.7.4. Flowonix Medical Inc.: SWOT Analysis
9.8. Fresenius SE & Co. KGaA
9.8.1. Overview
9.8.2. Fresenius Kabi: Product Portfolio
9.8.3. Financials
9.8.3.1. Financial Summary
9.8.4. Global Presence
9.8.5. Recent Developments
9.8.6. Fresenius SE & Co. KGaA: SWOT Analysis
9.9. Halyard Health, Inc.
9.9.1. Overview
9.9.2. Halyard Health,Inc.: Overall Product Portfolio
9.9.3. Financials
9.9.3.1. Financial Summary
9.9.4. Global Presence
9.9.5. Halyard Health, Inc.: SWOT Analysis
9.10. ICU Medical Inc.
9.10.1. Overview
9.10.2. ICU Medical Inc.: Product Portfolio
9.10.3. Financials
9.10.3.1. Financial Summary
9.10.4. Global Presence
9.10.5. Recent Developments
9.10.6. ICU Medical Inc.: SWOT Analysis
9.11. IRADIMED CORPORATION
9.11.1. Overview
9.11.2. IRADIMED CORPORATION: Product Portfolio
9.11.3. Financials
9.11.3.1 Financial Summary
9.11.4. Global Presence
9.11.5. Recent Developments
9.11.6. IRADIMED CORPORATION: SWOT Analysis
9.12. Insulet Corporation
9.12.1. Overview
9.12.2. Insulet Corporation: Product Portfolio
9.12.3. Financials
10.12.3.1. Financial Summary
9.12.4. Global Presence
9.12.5. Recent Developments
9.12.6. Insulet Corporation: SWOT Analysis
9.13. Medtronic Public Limited Company
9.13.1. Overview
9.13.2. Medtronic Public Limited Company: Product Portfolio
9.13.3. Financials
9.13.3.1. Financial Summary
9.13.4. Global Presence
9.13.5. Medtronic Public Limited Company: SWOT Analysis
9.14. MOOG, Inc.
9.14.1. Overview
9.14.2. MOOG, Inc.: Product Portfolio
9.14.3. Financials
9.14.3.1. Financial Summary
9.14.4. Global Presence
9.14.5. Recent Developments
9.14.6. MOOG, Inc.: SWOT Analysis
9.15. Smiths Group plc
9.15.1. Overview
9.15.2. Smiths Group plc: Product Portfolio
9.15.3. Financials
9.15.3.1. Financial Summary
9.15.4. Global Presence
9.15.5. Recent Developments
9.15.6. Smiths Group plc: SWOT Analysis
9.16. Tandem Diabetes Care, Inc.
9.16.1. Overview
9.16.2. Tandem Diabetes Care, Inc.: Product Portfolio
9.16.3. Financials
9.16.3.1. Financial Summary
9.16.4. Global Presence
9.16.5. Recent Developments
9.16.6. Tandem Diabetes Care, Inc.: SWOT Analysis
9.17. Terumo Corporation
9.17.1. Overview
9.17.2. Terumo corporation: Product Portfolio
9.17.3. Financials
9.17.3.1. Financial Summary
9.17.4. Global Presence
9.17.5. Terumo Corporation: SWOT Analysis
9.18. Zyno Medical, LLC
9.18.1. Overview
9.18.2. Corporate Summary
9.18.3. Zyno Medical, LLC: Product Portfolio
9.18.4. Recent Developments
9.18.5. Zyno Medical, LLC: SWOT Analysis
9.19. Snapshot of Other Key Players: Ivenix, Inc.
10 REPORT SCOPE
10.10.1. Scope of the Report
10.10.2 Global Drug Infusion Systems Market Segmentation
10.10.3 Research Methodology
10.10.3.1. Primary Research
10.10.3.2. Secondary Research
10.10.3.3. Key Data Points From Primary Sources
10.10.3.4. Key Data Points From Secondary Sources
10.10.3.5. Data Triangulation
10.10.3.6. Top-Down Approach (Segmental Analysis)
10.10.3.7. Bottom-Up Approach (Segmental Analysis)
10.10.4. Assumptions & Limitations
1 MARKET OVERVIEW
1.1. Introduction
1.2. Definition and Characterization
1.3. Infusion Systems Application
1.4. Market Size and Growth Potential
1.5. Technology Advancements
1.6. Pricing Analysis
1.7. Recent Product Launches
2 MARKET DYNAMICS
2.1. Market Drivers
2.2. Market Challenges
2.3. Market Opportunities
3 INDUSTRY INSIGHTS
3.1. Regulatory Scenario
3.2. Patent Landscape
4 COMPETITIVE LANDSCAPE
4.1. Share of Different Strategies
4.2. Porter's Five Force Analysis
4.3. Market Share Analysis
5 GLOBAL DRUG INFUSION SYSTEMS MARKET, BY PRODUCT
5.1. Introduction & Different Components of a Drug Infusion System
5.2. Market Segment
5.3. Large Volume Infusion Systems
5.4. Patient Controlled Analgesia
5.5. Elastomeric Infusion Pumps
5.6. Insulin Infusion Pumps
5.7. Syringe Infusion Systems
5.8. Implantable Infusion Systems
5.9. Ambulatory Infusion Systems
5.10. Enteral Infusion Systems
6 GLOBAL DRUG INFUSION SYSTEMS MARKET, BY APPLICATION
6.1. Introduction
6.2. Oncology/Chemotherapy
6.3. Diabetes
6.4. Analgesia
6.5. Nutrition
6.6. Haematology
6.7. Paediatrics
6.8. Other Applications
7 GLOBAL DRUG INFUSION SYSTEMS MARKET, BY END USER
7.1. Introduction
7.2. Different Types of End Users
8 GLOBAL DRUG INFUSION SYSTEMS MARKET, BY REGION
8.1. Introduction
8.2. North America
8.2.1. The U.S.
8.2.2. Canada
8.3. Europe
8.3.1. Austria
8.3.2. Belarus
8.3.3. Belgium
8.3.4. Denmark
8.3.5. Finland
8.3.6. France
8.3.7. Germany
8.3.8. Greece
8.3.9. Hungary
8.3.10. Ireland
8.3.11. Italy
8.3.12. Luxembourg
8.3.13. Netherlands
8.3.14 Norway
8.3.15. Poland
8.3.16. Portugal
8.3.17. Russia
8.3.18. Spain
8.3.19. Sweden
8.3.20 Switzerland
8.3.21. Turkey
8.3.22. Ukraine
8.3.23. The U.K.
8.4. Asia Pacific
8.4.1. Australia
8.4.2. Bangladesh
8.4.3. China
8.4.4. Hong Kong
8.4.5. India
8.4.6. Indonesia
8.4.7. Japan
8.4.8. South Korea
8.4.9. Malaysia
8.4.10. New Zealand
8.4.11. Pakistan
8.4.12. Philippines
8.4.13. Singapore
8.4.14. Taiwan
8.4.15. Thailand
8.4.16. Vietnam
8.5. Latin America & Middle East & Africa
8.5.1. Argentina
8.5.2. Brazil
8.5.3. Chile
8.5.4. Colombia
8.5.5. Mexico
8.5.6. Egypt
8.5.7. Iran
8.5.8. Israel
8.5.9. Kenya
8.5.10. Kuwait
8.5.11. Nigeria
8.5.12. Oman
8.5.13. Qatar
8.5.14. Saudi Arabia
8.5.15. South Africa
8.5.16. United Arab Emirates
9 COMPANY PROFILES
9.1. Acromed AG
9.1.1. Overview
9.1.2. Acromed AG: Corporate Summary
9.1.3. Acromed AG: Product Portfolio
9.1.4. Acromed AG: SWOT Analysis
9.2. B. Braun Melsungen AG
9.2.1. Overview
9.2.2. B. Braun Melsungen AG: Overall Product Portfolio
9.2.3. Financials
9.2.3.1. Financial Summary
9.2.4. Global Presence
9.2.5. Recent Developments
9.2.6. B.Braun Melsungen AG: SWOT Analysis
9.3. Baxter International Inc.
9.3.1. Overview
9.3.2. Baxter International Inc.: Product Portfolio
9.3.3. Financials
9.3.3.1 Financial Summary
9.3.4. Global Presence
9.3.5. Recent Developments
9.3.6. Baxter International Inc.: SWOT Analysis
9.4. Becton, Dickinson and Company
9.4.1. Overview
9.4.2. Becton, Dickinson and Company: Product Portfolio
9.4.3. Financials
9.4.3.1 Financial Summary
9.4.4. Global Presence
9.4.5. Recent Development
9.4.6. Becton, Dickinson and Company: SWOT Analysis
9.5. Caesarea Medical Electronics Ltd.
9.5.1. Overview
9.5.2. Corporate Summary
9.5.3. Caesarea Medical Electronics Ltd.: Product Portfolio
9.5.4. Caesarea Medical Electronics: SWOT Analysis
9.6. Debiotech S.A.
9.6.1. Overview
9.6.2 Corporate Summary & Product Portfolio
9.6.3. Debiotech S.A.: SWOT Analysis
9.7. Flowonix Medical Inc.
9.7.1. Overview
9.7.2. Corporate Summary & Product Portfolio
9.7.3. Recent Developments
9.7.4. Flowonix Medical Inc.: SWOT Analysis
9.8. Fresenius SE & Co. KGaA
9.8.1. Overview
9.8.2. Fresenius Kabi: Product Portfolio
9.8.3. Financials
9.8.3.1. Financial Summary
9.8.4. Global Presence
9.8.5. Recent Developments
9.8.6. Fresenius SE & Co. KGaA: SWOT Analysis
9.9. Halyard Health, Inc.
9.9.1. Overview
9.9.2. Halyard Health,Inc.: Overall Product Portfolio
9.9.3. Financials
9.9.3.1. Financial Summary
9.9.4. Global Presence
9.9.5. Halyard Health, Inc.: SWOT Analysis
9.10. ICU Medical Inc.
9.10.1. Overview
9.10.2. ICU Medical Inc.: Product Portfolio
9.10.3. Financials
9.10.3.1. Financial Summary
9.10.4. Global Presence
9.10.5. Recent Developments
9.10.6. ICU Medical Inc.: SWOT Analysis
9.11. IRADIMED CORPORATION
9.11.1. Overview
9.11.2. IRADIMED CORPORATION: Product Portfolio
9.11.3. Financials
9.11.3.1 Financial Summary
9.11.4. Global Presence
9.11.5. Recent Developments
9.11.6. IRADIMED CORPORATION: SWOT Analysis
9.12. Insulet Corporation
9.12.1. Overview
9.12.2. Insulet Corporation: Product Portfolio
9.12.3. Financials
10.12.3.1. Financial Summary
9.12.4. Global Presence
9.12.5. Recent Developments
9.12.6. Insulet Corporation: SWOT Analysis
9.13. Medtronic Public Limited Company
9.13.1. Overview
9.13.2. Medtronic Public Limited Company: Product Portfolio
9.13.3. Financials
9.13.3.1. Financial Summary
9.13.4. Global Presence
9.13.5. Medtronic Public Limited Company: SWOT Analysis
9.14. MOOG, Inc.
9.14.1. Overview
9.14.2. MOOG, Inc.: Product Portfolio
9.14.3. Financials
9.14.3.1. Financial Summary
9.14.4. Global Presence
9.14.5. Recent Developments
9.14.6. MOOG, Inc.: SWOT Analysis
9.15. Smiths Group plc
9.15.1. Overview
9.15.2. Smiths Group plc: Product Portfolio
9.15.3. Financials
9.15.3.1. Financial Summary
9.15.4. Global Presence
9.15.5. Recent Developments
9.15.6. Smiths Group plc: SWOT Analysis
9.16. Tandem Diabetes Care, Inc.
9.16.1. Overview
9.16.2. Tandem Diabetes Care, Inc.: Product Portfolio
9.16.3. Financials
9.16.3.1. Financial Summary
9.16.4. Global Presence
9.16.5. Recent Developments
9.16.6. Tandem Diabetes Care, Inc.: SWOT Analysis
9.17. Terumo Corporation
9.17.1. Overview
9.17.2. Terumo corporation: Product Portfolio
9.17.3. Financials
9.17.3.1. Financial Summary
9.17.4. Global Presence
9.17.5. Terumo Corporation: SWOT Analysis
9.18. Zyno Medical, LLC
9.18.1. Overview
9.18.2. Corporate Summary
9.18.3. Zyno Medical, LLC: Product Portfolio
9.18.4. Recent Developments
9.18.5. Zyno Medical, LLC: SWOT Analysis
9.19. Snapshot of Other Key Players: Ivenix, Inc.
10 REPORT SCOPE
10.10.1. Scope of the Report
10.10.2 Global Drug Infusion Systems Market Segmentation
10.10.3 Research Methodology
10.10.3.1. Primary Research
10.10.3.2. Secondary Research
10.10.3.3. Key Data Points From Primary Sources
10.10.3.4. Key Data Points From Secondary Sources
10.10.3.5. Data Triangulation
10.10.3.6. Top-Down Approach (Segmental Analysis)
10.10.3.7. Bottom-Up Approach (Segmental Analysis)
10.10.4. Assumptions & Limitations
LIST OF TABLES
1 DRUG INFUSION SYSTEMS MARKET, THE U.S. VS CHINA
2 RECENT PRODUCT LAUNCHES
3 GLOBAL REGULATORY SCENARIO
4 PATENT LANDSCAPE
5 EXAMPLES OF MARKETED LARGE VOLUME INFUSION PUMPS
6 EXAMPLES OF MARKETED PCA PUMPS
7 EXAMPLES OF MARKETED SYRINGE INFUSION SYSTEMS
8 GLOBAL INFUSION PUMPS MARKET, BY COUNTRY 2016-2025 ($MILLION)
9 GLOBAL INFUSION DISPOSABLES MARKET, BY COUNTRY 2016-2025 ($MILLION)
10 GLOBAL INFUSION ACCESSORIES MARKET, BY COUNTRY 2016-2025 ($MILLION)
11 PERCENTAGES OF POPULATION AGED 60 YEARS AND ABOVE
12 ARCOMED AG: OVERVIEW
13 B. BRAUN MELSUNGEN AG: OVERVIEW
14 B. BRAUN MELSUNGEN AG: RECENT DEVELOPMENTS
15 BAXTER INTERNATIONAL: OVERVIEW
16 BAXTER INTERNATIONAL: PRODUCT DEVELOPMENTS
17 BAXTER INTERNATIONAL: AWARDS & RECOGNITION
18 BECTON, DICKINSON AND COMPANY: OVERVIEW
19 BECTON, DICKINSON AND COMPANY: PRODUCT DEVELOPMENT
20 CAESAREA MEDICAL ELECTRONICS LTD.: OVERVIEW
21 DEBIOTECH S.A.: OVERVIEW
22 FLOWONIX MEDICAL INC.: OVERVIEW
23 FLOWONIX MEDICAL INC.: PRODUCT DEVELOPMENT
24 FRESENIUS SE & CO. KGAA: OVERVIEW
25 FRESENIUS SE & CO. KGAA: RECENT DEVELOPMENTS
26 HALYARD HEALTH, INC.: OVERVIEW
27 ICU MEDICAL INC.: OVERVIEW
28 ICU MEDICAL INC.: RECENT DEVELOPMENTS
29 IRADIMED CORPORATION: OVERVIEW
30 IRADIMED CORPORATION: RECENT DEVELOPMENT
31 INSULET CORPORATION: OVERVIEW
32 INSULET CORPORATION: ACQUISITIONS, COLLABORATIONS, AND AGREEMENTS
33 MEDTRONIC PUBLIC LIMITED COMPANY: OVERVIEW
32 MOOG, INC.: OVERVIEW
33 MOOG, INC.: PRODUCT DEVELOPMENTS
34 SMITHS GROUP PLC: OVERVIEW
35 SMITHS GROUP PLC: RECENT DEVELOPMENTS
36 TANDEM DIABETES CARE, INC.: OVERVIEW
37 TANDEM DIABETES CARE, INC.: RECENT DEVELOPMENTS
38 TERUMO CORPORATION: OVERVIEW
39 ZYNOMEDICAL, LLC: OVERVIEW
40 ZYNO MEDICAL, LLC: RECENT DEVELOPMENTS
41 IVENIX, INC.: OVERVIEW
1 DRUG INFUSION SYSTEMS MARKET, THE U.S. VS CHINA
2 RECENT PRODUCT LAUNCHES
3 GLOBAL REGULATORY SCENARIO
4 PATENT LANDSCAPE
5 EXAMPLES OF MARKETED LARGE VOLUME INFUSION PUMPS
6 EXAMPLES OF MARKETED PCA PUMPS
7 EXAMPLES OF MARKETED SYRINGE INFUSION SYSTEMS
8 GLOBAL INFUSION PUMPS MARKET, BY COUNTRY 2016-2025 ($MILLION)
9 GLOBAL INFUSION DISPOSABLES MARKET, BY COUNTRY 2016-2025 ($MILLION)
10 GLOBAL INFUSION ACCESSORIES MARKET, BY COUNTRY 2016-2025 ($MILLION)
11 PERCENTAGES OF POPULATION AGED 60 YEARS AND ABOVE
12 ARCOMED AG: OVERVIEW
13 B. BRAUN MELSUNGEN AG: OVERVIEW
14 B. BRAUN MELSUNGEN AG: RECENT DEVELOPMENTS
15 BAXTER INTERNATIONAL: OVERVIEW
16 BAXTER INTERNATIONAL: PRODUCT DEVELOPMENTS
17 BAXTER INTERNATIONAL: AWARDS & RECOGNITION
18 BECTON, DICKINSON AND COMPANY: OVERVIEW
19 BECTON, DICKINSON AND COMPANY: PRODUCT DEVELOPMENT
20 CAESAREA MEDICAL ELECTRONICS LTD.: OVERVIEW
21 DEBIOTECH S.A.: OVERVIEW
22 FLOWONIX MEDICAL INC.: OVERVIEW
23 FLOWONIX MEDICAL INC.: PRODUCT DEVELOPMENT
24 FRESENIUS SE & CO. KGAA: OVERVIEW
25 FRESENIUS SE & CO. KGAA: RECENT DEVELOPMENTS
26 HALYARD HEALTH, INC.: OVERVIEW
27 ICU MEDICAL INC.: OVERVIEW
28 ICU MEDICAL INC.: RECENT DEVELOPMENTS
29 IRADIMED CORPORATION: OVERVIEW
30 IRADIMED CORPORATION: RECENT DEVELOPMENT
31 INSULET CORPORATION: OVERVIEW
32 INSULET CORPORATION: ACQUISITIONS, COLLABORATIONS, AND AGREEMENTS
33 MEDTRONIC PUBLIC LIMITED COMPANY: OVERVIEW
32 MOOG, INC.: OVERVIEW
33 MOOG, INC.: PRODUCT DEVELOPMENTS
34 SMITHS GROUP PLC: OVERVIEW
35 SMITHS GROUP PLC: RECENT DEVELOPMENTS
36 TANDEM DIABETES CARE, INC.: OVERVIEW
37 TANDEM DIABETES CARE, INC.: RECENT DEVELOPMENTS
38 TERUMO CORPORATION: OVERVIEW
39 ZYNOMEDICAL, LLC: OVERVIEW
40 ZYNO MEDICAL, LLC: RECENT DEVELOPMENTS
41 IVENIX, INC.: OVERVIEW
LIST OF FIGURES
1 CHRONIC CONDITIONS: KEY STATISTICS: 2016
2 MARKET DRIVERS AND CHALLENGES
3 GLOBAL DRUG INFUSION SYSTEMS MARKET, BY COMPONENTS, 2016
4 GLOBAL DRUG INFUSION SYSTEMS MARKET, BY COMPONENTS, 2025
5 GLOBAL DRUG INFUSION SYSTEMS MARKET, BY INFUSION SYSTEM TYPE, 2016
6 GLOBAL DRUG INFUSION SYSTEMS MARKET, BY INFUSION SYSTEM TYPE, 2025
7 GLOBAL DRUG INFUSION SYSTEMS MARKET, BY APPLICATION, 2016
8 GLOBAL DRUG INFUSION SYSTEMS MARKET, BY APPLICATION, 2025
9 GLOBAL DRUG INFUSION SYSTEMS MARKET, BY END USER, 2016
10 GLOBAL DRUG INFUSION SYSTEMS MARKET, BY END USER, 2025
11 GLOBAL DRUG INFUSION SYSTEMS MARKET, BY REGION, 2016
12 GLOBAL DRUG INFUSION SYSTEMS MARKET, BY REGION, 2025
13 GLOBAL DRUG INFUSION SYSTEMS MARKET
14 MARKET SHARE ANALYSIS
15 ADVANTAGES OF DRUG INFUSION SYSTEMS
16 DESIRABLE CHARACTERISTICS OF DRUG INFUSION SYSTEMS
17 GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE & GROWTH POTENTIAL, BY PRODUCT TYPE
18 GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE & GROWTH POTENTIAL, BY END USER
19 GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE & GROWTH POTENTIAL, BY APPLICATION
20 NUMBER OF PEOPLE WITH CHRONIC CONDITIONS (U.S.) IN MILLION
21 INFUSION PUMP RECALLS, 2010-2017
22 PER DAY COST SAVINGS VS. HOSPITALS
23 SHARE OF DIFFERENT STRATEGIES
24 PORTER'S FIVE FORCES ANALYSIS
25 MARKET SHARE ANALYSIS
26 COMPONENTS OF DRUG INFUSION SYSTEMS
27 GLOBAL DRUG INFUSION SYSTEMS MARKET, BY COMPONENTS
28 SEGMENTATION OF GLOBAL DRUG INFUSION SYSTEMS MARKET, BY PRODUCT
29 GLOBAL DRUG INFUSION SYSTEMS MARKET, BY PRODUCT, 2016-2025 ($MILLION)
30 GLOBAL LARGE VOLUME INFUSION SYSTEMS MARKET, 2016-2025 ($MILLION)
31 GLOBAL PCA INFUSION SYSTEMS MARKET, 2016-2025 ($MILLION)
32 GLOBAL ELASTOMERIC INFUSION SYSTEMS MARKET, 2016-2025 ($MILLION)
33 GLOBAL INSULIN INFUSION SYSTEMS MARKET, 2016-2025 ($MILLION)
34 GLOBAL SYRINGE INFUSION SYSTEMS MARKET, 2016-2025 ($MILLION)
35 GLOBAL IMPLANTABLE INFUSION SYSTEMS MARKET, 2016-2025 ($MILLION)
36 ADVANTAGES & DISADVANTAGES OF IMPLANTABLE INFUSION SYSTEMS
37 GLOBAL AMBULATORY INFUSION SYSTEMS MARKET, 2016-2025 ($MILLION)
38 GLOBAL ENTERAL INFUSION SYSTEMS MARKET, 2016-2025 ($MILLION)
39 APPLICATIONS OF INFUSION SYSTEMS
40 GLOBAL DRUG INFUSION SYSTEMS MARKET, BY APPLICATION, 2016-2025 ($MILLION)
41 GLOBAL ONCOLOGY INFUSION SYSTEMS MARKET, 2016-2025, ($MILLION)
42 NUMBER OF NEW CANCER CASES
43 TYPES OF DIABETES MELLITUS
44 GLOBAL PATIENTS DIAGNOSED WITH DIABETES
45 GLOBAL DIABETES INFUSION SYSTEMS MARKET, 2016-2025, ($MILLION)
46 GLOBAL ANALGESIA INFUSION SYSTEMS MARKET, 2016-2025, ($MILLION)
47 MOST COMMON TYPES OF CHRONIC PAIN
48 GLOBAL NUTRITION INFUSION SYSTEMS MARKET, 2016-2025, ($MILLION)
49 GLOBAL HAEMATOLOGY INFUSION SYSTEMS MARKET, 2016-2025, ($MILLION)
50 GLOBAL PAEDIATRICS INFUSION SYSTEMS MARKET, 2016-2025, ($MILLION)
51 GLOBAL OTHERS INFUSION SYSTEMS MARKET, 2016-2025, ($MILLION)
52 GLOBAL DRUG INFUSION SYSTEMS MARKET, END USER
53 GLOBAL DRUG INFUSION SYSTEMS MARKET, BY END USER, 2016-2025 ($MILLION)
54 GLOBAL DRUG INFUSION SYSTEMS MARKET, BY REGION, 2016-2025 ($MILLION)
55 NORTH AMERICA DRUG INFUSION SYSTEMS MARKET 2016-2025 ($MILLION)
56 NORTH AMERICA DRUG INFUSION SYSTEMS MARKET, BY COMPONENTS 2016-2025 ($MILLION)
57 THE U.S. DRUG INFUSION SYSTEMS MARKET, BY VALUE, 2016-2025 ($MILLION)
58 THE U.S. DRUG INFUSION SYSTEMS MARKET, BY TYPE 2016-2025($MILLION)
59 CANADIAN DRUG INFUSION SYSTEMS MARKET, BY VALUE, 2016-2025 ($MILLION)
60 CANADIAN DRUG INFUSION PUMPS MARKET, BY TYPE 2016-2025($MILLION)
61 EUROPEAN DRUG INFUSION SYSTEMS MARKET,2016-2025 ($MILLION)
62 EUROPEAN DRUG INFUSION SYSTEMS MARKET, BY COMPONENTS, 2016-2025 ($MILLION)
63 AUSTRIA DRUG INFUSION PUMPS MARKET, BY VALUE, 2016-2025 ($MILLION)
64 AUSTRIA DRUG INFUSION PUMPS MARKET, BY TYPE 2016-2025($MILLION)
65 BELARUS DRUG INFUSION SYSTEMS MARKET, BY VALUE, 2016-2025 ($MILLION)
66 BELARUS DRUG INFUSION PUMPS MARKET, BY TYPE 2016-2025($MILLION)
67 BELGIUM DRUG INFUSION SYSTEMS MARKET, BY VALUE, 2016-2025 ($MILLION)
68 BELGIUM DRUG INFUSION SYSTEMS MARKET, BY TYPE 2016-2025
69 DENMARK DRUG INFUSION SYSTEMS MARKET, BY VALUE, 2016-2025 ($MILLION)
70 DENMARK DRUG INFUSION SYSTEMS MARKET, BY TYPE 2016-2025
71 FINLAND DRUG INFUSION SYSTEMS MARKET, BY VALUE, 2016-2025 ($MILLION)
72 FINLAND DRUG INFUSION SYSTEMS MARKET, BY TYPE 2016-2025 ($MILLION)
73 FRANCE DRUG INFUSION SYSTEMS MARKET, BY VALUE, 2016-2025 ($MILLION)
74 FRANCE DRUG INFUSION PUMPS MARKET, BY VOLUME 2016-2025 ($MILLION)
75 GERMANY DRUG INFUSION PUMPS MARKET, BY VALUE, 2016-2025 ($MILLION)
76 GERMANY DRUG INFUSION PUMPS MARKET, BY TYPE 2016-2025 ($MILLION)
77 GREECE DRUG INFUSION SYSTEMS MARKET, BY VALUE, 2016-2025 ($MILLION)
78 GREECE DRUG INFUSION SYSTEMS MARKET, BY TYPE 2016-2025 ($MILLION)
79 HUNGARY DRUG INFUSION SYSTEMS MARKET, BY VALUE, 2016-2025 ($MILLION)
80 HUNGARY DRUG INFUSION SYSTEMS MARKET, BY TYPE 2016-2025 ($MILLION)
81 IRELAND DRUG INFUSION SYSTEMS MARKET, BY VALUE, 2016-2025 ($MILLION)
82 IRELAND DRUG INFUSION SYSTEMS MARKET, BY TYPE 2016-2025 ($MILLION)
83 ITALY DRUG INFUSION SYSTEMS MARKET, BY VALUE, 2016-2025 ($MILLION)
84 ITALY DRUG INFUSION SYSTEMS MARKET, BY TYPE 2016-2025 ($MILLION)
85 LUXEMBOURG DRUG INFUSION SYSTEMS MARKET, BY VALUE, 2016-2025 ($MILLION)
86 LUXEMBOURG DRUG INFUSION SYSTEMS MARKET, BY TYPE 2016-2025 ($MILLION)
87 NETHERLANDS DRUG INFUSION SYSTEMS MARKET, BY VALUE, 2016-2025 ($MILLION)
88 NETHERLANDS DRUG INFUSION SYSTEMS MARKET, BY TYPE 2016-2025 ($MILLION)
89 NORWAY DRUG INFUSION SYSTEMS MARKET, BY VALUE, 2016-2025 ($MILLION)
90 NORWAY DRUG INFUSION SYSTEMS MARKET, BY TYPE 2016-2025 ($MILLION)
91 POLAND DRUG INFUSION SYSTEMS MARKET, BY VALUE, 2016-2025 ($MILLION)
92 POLAND DRUG INFUSION SYSTEMS MARKET, BY TYPE 2016-2025 ($MILLION)
93 PORTUGAL DRUG INFUSION SYSTEMS MARKET, BY VALUE, 2016-2025 ($MILLION)
94 PORTUGAL DRUG INFUSION SYSTEMS MARKET, BY TYPE 2016-2025 ($MILLION)
95 RUSSIA DRUG INFUSION SYSTEMS MARKET, BY VALUE, 2016-2025 ($MILLION)
96 RUSSIA DRUG INFUSION SYSTEMS MARKET, BY TYPE 2016-2025 ($MILLION)
97 SPAIN DRUG INFUSION SYSTEMS MARKET, BY VALUE, 2016-2025 ($MILLION)
98 SPAIN DRUG INFUSION SYSTEMS MARKET, BY TYPE 2016-2025 ($MILLION)
99 SWEDEN DRUG INFUSION PUMPS MARKET, BY VALUE, 2016-2025 ($MILLION)
100 SWEDEN DRUG INFUSION PUMPS MARKET, BY TYPE 2016-2025 ($MILLION)
101 SWITZERLAND DRUG INFUSION SYSTEMS MARKET, BY VALUE, 2016-2025 ($MILLION)
102 SWITZERLAND DRUG INFUSION SYSTEMS MARKET, BY TYPE 2016-2025 ($MILLION)
103 TURKEY DRUG INFUSION SYSTEMS MARKET, BY VALUE, 2016-2025 ($MILLION)
104 TURKEY DRUG INFUSION SYSTEMS MARKET, BY TYPE 2016-2025 ($MILLION)
105 UKRAINE DRUG INFUSION SYSTEMS MARKET, BY VALUE, 2016-2025 ($MILLION)
106 UKRAINE DRUG INFUSION SYSTEMS MARKET, BY TYPE 2016-2025 ($MILLION)
107 THE U.K. DRUG INFUSION SYSTEMS MARKET, BY VALUE, 2016-2025 ($MILLION)
108 THE U.K. DRUG INFUSION SYSTEMS MARKET, BY TYPE 2016-2025 ($MILLION)
109 ASIA PACIFIC DRUG INFUSION SYSTEMS MARKET, 2016-2025, ($MILLION)
110 ASIA PACIFIC DRUG INFUSION SYSTEMS MARKET, BY COMPONENT, 2016-2025 ($MILLION)
111 AUSTRALIAN DRUG INFUSION SYSTEMS MARKET, BY VALUE, 2016-2025 ($MILLION)
112 AUSTRALIAN DRUG INFUSION SYSTEMS MARKET, BY TYPE 2016-2025 ($MILLION)
113 ASIA PACIFIC DRUG INFUSION SYSTEMS MARKET, BY COMPONENT, 2016-2025 ($MILLION)
114 AUSTRALIAN DRUG INFUSION SYSTEMS MARKET, BY VALUE, 2016-2025 ($MILLION)
115 AUSTRALIAN DRUG INFUSION SYSTEMS MARKET, BY TYPE 2016-2025 ($MILLION)
116 BANGLADESH DRUG INFUSION SYSTEMS MARKET, BY VALUE, 2016-2025 ($MILLION)
117 BANGLADESH DRUG INFUSION PUMPS MARKET, BY TYPE 2016-2025 ($MILLION)
118 CHINA DRUG INFUSION PUMPS MARKET, BY VALUE, 2016-2025 ($MILLION)
119 CHINA DRUG INFUSION SYSTEMS MARKET, BY TYPE 2016-2025 ($MILLION)
120 HONG KONG DRUG INFUSION SYSTEMS MARKET, BY VALUE, 2016-2025 ($MILLION)
121 HONG KONG DRUG INFUSION SYSTEMS MARKET, BY TYPE 2016-2025 ($MILLION)
122 INDIA DRUG INFUSION SYSTEMS MARKET, BY VALUE, 2016-2025 ($MILLION)
123 INDIA DRUG INFUSION SYSTEMS MARKET, BY TYPE 2016-2025 ($MILLION)
124 INDONESIA DRUG INFUSION SYSTEMS MARKET, BY VALUE, 2016-2025 ($MILLION)
125 INDONESIA DRUG INFUSION SYSTEMS MARKET, BY TYPE 2016-2025 ($MILLION)
126 JAPAN DRUG INFUSION PUMPS MARKET, BY VALUE, 2016-2025 ($MILLION)
127 JAPAN DRUG INFUSION SYSTEMS MARKET, BY TYPE 2016-2025($MILLION)
128 SOUTH KOREA DRUG INFUSION PUMPS MARKET, BY VALUE, 2016-2025 ($MILLION)
129 SOUTH KOREA DRUG INFUSION SYSTEMS MARKET, BY TYPE 2016-2025 ($MILLION)
130 MALAYSIA DRUG INFUSION SYSTEMS MARKET, BY VALUE, 2016-2025 ($MILLION)
131 MALAYSIA DRUG INFUSION SYSTEMS MARKET, BY TYPE 2016-2025 ($MILLION)
132 NEW ZEALAND DRUG INFUSION SYSTEMS MARKET, BY VALUE, 2016-2025 ($MILLION)
133 NEW ZEALAND DRUG INFUSION SYSTEMS MARKET, BY TYPE 2016-2025 ($MILLION)
134 PAKISTAN DRUG INFUSION SYSTEMS MARKET, BY VALUE, 2016-2025 ($MILLION)
135 PAKISTAN DRUG INFUSION SYSTEMS MARKET, BY TYPE 2016-2025 ($MILLION)
136 PHILIPPINES DRUG INFUSION SYSTEMS MARKET, BY VALUE, 2016-2025 ($MILLION)
137 PHILIPPINES DRUG INFUSION SYSTEMS MARKET, BY TYPE 2016-2025 ($MILLION)
138 SINGAPORE DRUG INFUSION SYSTEMS MARKET, BY VALUE, 2016-2025 ($MILLION)
139 SINGAPORE DRUG INFUSION SYSTEMS MARKET, BY TYPE 2016-2025 ($MILLION)
140 TAIWAN DRUG INFUSION SYSTEMS MARKET, BY VALUE, 2016-2025 ($MILLION)
141 TAIWAN DRUG INFUSION SYSTEMS MARKET, BY TYPE 2016-2025 ($MILLION)
142 THAILAND DRUG INFUSION SYSTEMS MARKET, BY VALUE, 2016-2025 ($MILLION)
143 THAILAND DRUG INFUSION SYSTEMS MARKET, BY TYPE 2016-2025 ($MILLION)
144 VIETNAM DRUG INFUSION SYSTEMS MARKET, BY VALUE, 2016-2025 ($MILLION)
145 VIETNAM DRUG INFUSION SYSTEMS MARKET, BY TYPE 2016-2025 ($MILLION)
146 LATIN AMERICA DRUG INFUSION SYSTEMS MARKET, 2016-2025 ($MILLION)
147 LATIN AMERICA DRUG INFUSION SYSTEMS MARKET, BY COMPONENTS 2016-2025 ($MILLION)
148 ARGENTINA DRUG INFUSION PUMPS MARKET, BY VALUE, 2016-2025 ($MILLION)
149 ARGENTINA DRUG INFUSION PUMPS MARKET, BY TYPE 2016-2025 ($MILLION)
150 BRAZIL DRUG INFUSION SYSTEMS MARKET, BY VALUE, 2016-2025 ($MILLION)
151 BRAZIL DRUG INFUSION SYSTEMS MARKET, BY TYPE 2016-2025 ($MILLION)
152 CHILE DRUG INFUSION SYSTEMS MARKET, BY VALUE, 2016-2025 ($MILLION)
153 CHILE DRUG INFUSION PUMPS MARKET, BY TYPE 2016-2025 ($MILLION)
154 COLOMBIA DRUG INFUSION SYSTEMS MARKET, BY VALUE, 2016-2025 ($MILLION)
155 COLOMBIA DRUG INFUSION SYSTEMS MARKET, BY TYPE 2016-2025 ($MILLION)
156 MEXICO DRUG INFUSION SYSTEMS MARKET, BY VALUE, 2016-2025 ($MILLION)
157 MEXICO DRUG INFUSION SYSTEMS MARKET, BY TYPE 2016-2025 ($MILLION)
158 MEA DRUG INFUSION SYSTEMS MARKET, 2016-2025 ($MILLION)
159 MEA DRUG INFUSION SYSTEMS MARKET, BY COMPONENT 2016-2025 ($MILLION)
160 EGYPT DRUG INFUSION SYSTEMS MARKET, BY VALUE, 2016-2025 ($MILLION)
161 EGYPT DRUG INFUSION SYSTEMS MARKET, BY TYPE, 2016-2025 ($MILLION)
162 IRAN DRUG INFUSION PUMPS MARKET, BY VALUE, 2016-2025 ($MILLION)
163 IRAN DRUG INFUSION PUMPS MARKET, BY TYPE, 2016-2025 ($MILLION)
164 ISRAEL DRUG INFUSION SYSTEMS MARKET, BY VALUE, 2016-2025 ($MILLION)
165 ISRAEL DRUG INFUSION SYSTEMS MARKET, BY TYPE 2016-2025
166 KENYA DRUG INFUSION SYSTEMS MARKET, BY VALUE, 2016-2025 ($MILLION)
167 KENYA DRUG INFUSION SYSTEMS MARKET, BY TYPE, 2016-2025 ($MILLION)
168 KUWAIT DRUG INFUSION SYSTEMS MARKET, BY VALUE, 2016-2025 ($MILLION)
169 KUWAIT DRUG INFUSION SYSTEMS MARKET, BY TYPE 2016-2025 ($MILLION)
170 NIGERIA DRUG INFUSION SYSTEMS MARKET, BY VALUE, 2016-2025 ($MILLION)
171 NIGERIA DRUG INFUSION PUMPS MARKET, BY TYPE, 2016-2025 ($MILLION)
172 OMAN DRUG INFUSION SYSTEMS MARKET, BY VALUE, 2016-2025 ($MILLION)
173 OMAN DRUG INFUSION SYSTEMS MARKET, BY TYPE, 2016-2025 ($MILLION)
174 QATAR DRUG INFUSION SYSTEMS MARKET, BY VALUE, 2016-2025 ($MILLION)
175 QATAR DRUG INFUSION SYSTEMS MARKET, BY TYPE 2016-2025 ($MILLION)
176 SAUDI ARABIA DRUG INFUSION SYSTEMS MARKET, BY VALUE, 2016-2025 ($MILLION)
177 SAUDI ARABIA DRUG INFUSION SYSTEMS MARKET, BY TYPE 2016-2025 ($MILLION)
178 SOUTH AFRICA DRUG INFUSION PUMPS MARKET, BY VALUE, 2016-2025 ($MILLION)
179 SOUTH AFRICA DRUG INFUSION SYSTEMS MARKET, BY TYPE 2016-2025 ($MILLION)
180 UNITED ARAB EMIRATES DRUG INFUSION SYSTEMS MARKET, BY VALUE, 2016-2025 ($MILLION)
181 UNITED ARAB EMIRATES DRUG INFUSION PUMPS MARKET, BY TYPE 2016-2025 ($MILLION)
182 ARCOMED AG: OVERALL PRODUCT PORTFOLIO
183 ARCOMED AG: PRODUCT PORTFOLIO OF DRUG INFUSION SYSTEMS
184 ARCOMED AG: SWOT ANALYSIS
185 B.BRAUN MELSUNGEN AG: OVERALL PRODUCT PORTFOLIO
186 B.BRAUN MELSUNGEN AG: PRODUCT PORTFOLIO OF DRUG INFUSION SYSTEMS
187 B. BRAUN MELSUNGEN AG: OVERALL FINANCIALS (2014-2016)
188 B. BRAUN MELSUNGEN AG: NET REVENUE BY REGION (2014-2016)
189 B. BRAUN MELSUNGEN AG: REVENUE BY DIVISION (2014-2016)
190 B.BRAUN MELSUNGEN AG:GLOBAL PRESENCE
191 B. BRAUN MELSUNGEN AG: SWOT ANALYSIS
192 BAXTER INTERNATIONAL INC.: OVERALL PRODUCT PORTFOLIO
193 BAXTER INTERNATIONAL INC. : PRODUCT PORTFOLIO OF DRUG INFUSION SYSTEMS
194 BAXTER INTERNATIONAL INC.: OVERALL FINANCIALS (2014-2016)
195 BAXTER INTERNATIONAL INC.: NET REVENUE BY REGION (2014-2016)
196 BAXTER INTERNATIONAL INC.: REVENUE BY SEGMENT (2014-2016)
197 BAXTER INTERNATIONAL INC.: REVENUE BY HOSPITAL PRODUCTS SUB-SEGMENT (2014-2016)
198 BAXTER INTERNATIONAL INC: GLOBAL PRESENCE
199 BAXTER INTERNATIONAL INC.: SWOT ANALYSIS
200 BECTON, DICKINSON AND COMPANY: OVERALL PRODUCT PORTFOLIO
201 BECTON, DICKINSON AND COMPANY: OVERALL FINANCIALS (2015-2017)
202 BECTON, DICKINSON AND COMPANY: NET REVENUE BY REGION (2015-2017)
203 BECTON, DICKINSON AND COMPANY: REVENUE BY BUSINESS SEGMENT (2015-2017)
204 BECTON, DICKINSON AND COMPANY: REVENUE BY SUB-SEGMENT (2015-2017)
205 BECTON, DICKINSON AND COMPANY: GLOBAL PRESENCE
206 BECTON, DICKINSON AND COMPANY: SWOT ANALYSIS
207 CAESAREA MEDICAL ELECTRONICS LTD.: OVERALL PRODUCT PORTFOLIO
208 CAESAREA MEDICAL ELECTRONICS LTD.: PRODUCT PORTFOLIO
209 CAESAREA MEDICAL ELECTRONICS LTD.: SWOT ANALYSIS
210 DEBIOTECH S.A.: OVERALL PRODUCT PORTFOLIO
211 PRODUCT PORTFOLIO FOR DEBIOTECH TECHNOLOGIES SEGMENT
212 DEBIOTECH S.A.: SWOT ANALYSIS
213 FLOWONIX MEDICAL INC.: OVERALL PRODUCT PORTFOLIO
214 FLOWONIX MEDICAL INC.: DRUG INFUSION SYSTEMS PRODUCT PORTFOLIO
215 FLOWONIX MEDICAL INC.: SWOT ANALYSIS
216 FRESENIUS SE & CO. KGAA: OVERALL PRODUCT PORTFOLIO
217 PRODUCT PORTFOLIO FOR FRESENIUS KABI
218 FRESENIUS SE & CO. KGAA: OVERALL FINANCIALS (2014-2016)
219 FRESENIUS KABI: REVENUE BY REGION (2014-2016)
220 FRESENIUS SE & CO. KGAA: REVENUE BY SEGMENT (2014-2016)
221 FRESENIUS SE & CO. KGAA: REVENUE BY SUB-SEGMENT (2014-2016)
222 FRESENIUS SE & CO. KGAA: GLOBAL PRESENCE
223 FRESENIUS SE & CO. KGAA: SWOT ANALYSIS
224 HALYARD HEALTH, INC.: OVERALL PRODUCT PORTFOLIO
225 HALYARD HEALTH, INC.: DRUG INFUSION SYSTEMS PRODUCT PORTFOLIO
226 HALYARD HEALTH, INC.: OVERALL FINANCIALS (2014-2016)
227 HALYARD HEALTH, INC.: REVENUE BY REGION (2015-2017)
228 HALYARD HEALTH, INC.: REVENUE BY BUSINESS SEGMENT (2015-2017)
229 HALYARD HEALTH, INC.: GLOBAL PRESENCE
230 HALYARD HEALTH, INC.: SWOT ANALYSIS
231 ICU MEDICAL INC.: OVERALL PRODUCT PORTFOLIO
232 ICU MEDICAL INC.: PRODUCT PORTFOLIO OF DRUG INFUSION SYSTEMS
233 ICU MEDICAL INC.: OVERALL FINANCIALS (2014-2016)
234 ICU MEDICAL INC.: REVENUE BY SEGMENT (2014-2016)
235 ICU MEDICAL INC.: REVENUE BY SUB-SEGMENT (2014-2016)
236 ICU MEDICAL INC.: GLOBAL PRESENCE
237 ICU MEDICAL INC.: SWOT ANALYSIS
238 IRADIMED CORPORATION: PRODUCT PORTFOLIO OF DRUG INFUSION SYSTEMS
239 IRADIMED CORPORATION: OVERALL FINANCIALS (2014-2016)
240 IRADIMED CORPORATION: REVENUE BY REGION (2014-2016)
241 IRADIMED CORPORATION: REVENUE BY BUSINESS SEGMENT (2015-2017)
242 IRADIMED CORPORATION: GLOBAL PRESENCE
243 IRADIMED CORPORATION:SWOT ANALYSIS
244 INSULET CORPORATION: OVERALL PRODUCT PORTFOLIO
245 INSULET CORPORATION: PRODUCT PORTFOLIO OF DRUG INFUSION SYSTEMS
246 INSULET CORPORATION: OVERALL FINANCIALS (2014-2016)
247 INSULET CORPORATION: REVENUE BY REGION (2014-2016)
248 INSULET CORPORATION: REVENUE BY BUSINESS SEGMENT (2014-2016)
249 INSULET CORPORATION: GLOBAL PRESENCE
250 INSULET CORPORATION: SWOT ANALYSIS
251 MEDTRONIC PUBLIC LIMITED COMPANY: OVERALL PRODUCT PORTFOLIO
252 MEDTRONIC PUBLIC LIMITED COMPANY: PRODUCT PORTFOLIO OF DRUG INFUSION SYSTEMS
253 MEDTRONIC PUBLIC LIMITED COMPANY: OVERALL FINANCIALS (2015-2017)
254 MEDTRONIC PUBLIC LIMITED COMPANY: NET REVENUE BY REGION (2015-2017)
255 MEDTRONIC PUBLIC LIMITED COMPANY: REVENUE BY BUSINESS SEGMENT (2015-2017)
256 MEDTRONIC PUBLIC LIMITED COMPANY: REVENUE BY SUB-SEGMENT (2015-2017)
257 MEDTRONIC PUBLIC LIMITED COMPANY: GLOBAL PRESENCE
258 MEDTRONIC PUBLIC LIMITED COMPANY: SWOT ANALYSIS
259 MOOG, INC.: OVERALL PRODUCT PORTFOLIO
260 MOOG, INC.: PRODUCT PORTFOLIO OF DRUG INFUSION SYSTEMS
261 MOOG, INC.: OVERALL FINANCIALS (2015-2017)
262 MOOG, INC.: REVENUE BY SEGMENT (2015-2017)
263 MOOG, INC.: GLOBAL PRESENCE
264 MOOG, INC. SWOT ANALYSIS
265 SMITHS GROUP PLC: OVERALL PRODUCT PORTFOLIO
266 SMITHS GROUP PLC: PRODUCT PORTFOLIO OF DRUG INFUSION SYSTEMS
267 SMITHS GROUP PLC: OVERALL FINANCIALS (2015-2017)
268 SMITHS GROUP PLC: NET REVENUE BY REGION (2015-2016)
269 SMITHS GROUP PLC: NET REVENUE BY REGION, 2017
270 SMITHS GROUP PLC: REVENUE BY DIVISION (2015-2017)
271 SMITHS GROUP PLC.: REVENUE BY SMITHS MEDICAL SUB-DIVISION (2015-2017)
272 SMITHS GROUP PLC.: GLOBAL PRESENCE
273 SMITHS GROUP PLC SWOT ANALYSIS
274 TANDEM DIABETES CARE, INC.: OVERALL PRODUCT PORTFOLIO
275 TANDEM DIABETES CARE, INC.: PRODUCTS UNDER DEVELOPMENT
276 TANDEM DIABETES CARE: OVERALL FINANCIALS (2014-2016)
277 TANDEM DIABETES CARE: GLOBAL PRESENCE
278 TANDEM DIABETES CARE, INC.: SWOT ANALYSIS
279 TERUMO CORPORATION: OVERALL PRODUCT PORTFOLIO
280 TERUMO CORPORATION: PRODUCT PORTFOLIO OF DRUG INFUSION SYSTEMS
281 TERUMO CORPORATION: OVERALL FINANCIALS (2015-2017)
282 TERUMO CORPORATION: NET REVENUE BY REGION (2015-2017)
283 TERUMO CORPORATION: REVENUE BY BUSINESS SEGMENT (2015-2017)
284 TERUMO CORPORATION: REVENUE BY SUB-SEGMENT (2015-2017)
285 TERUMO CORPORATION: GLOBAL PRESENCE
286 TERUMO CORPORATION: SWOT ANALYSIS
287 ZYNO MEDICAL, LLC: OVERALL PRODUCT PORTFOLIO
288 ZYNO MEDICAL, LLC: PRODUCT PORTFOLIO OF DRUG INFUSION SYSTEMS
289 ZYNO MEDICAL, LLC: SWOT ANALYSIS
290 GLOBAL INFUSION SYSTEMS MARKET SEGMENTATION
291 DATA TRIANGULATION
1 CHRONIC CONDITIONS: KEY STATISTICS: 2016
2 MARKET DRIVERS AND CHALLENGES
3 GLOBAL DRUG INFUSION SYSTEMS MARKET, BY COMPONENTS, 2016
4 GLOBAL DRUG INFUSION SYSTEMS MARKET, BY COMPONENTS, 2025
5 GLOBAL DRUG INFUSION SYSTEMS MARKET, BY INFUSION SYSTEM TYPE, 2016
6 GLOBAL DRUG INFUSION SYSTEMS MARKET, BY INFUSION SYSTEM TYPE, 2025
7 GLOBAL DRUG INFUSION SYSTEMS MARKET, BY APPLICATION, 2016
8 GLOBAL DRUG INFUSION SYSTEMS MARKET, BY APPLICATION, 2025
9 GLOBAL DRUG INFUSION SYSTEMS MARKET, BY END USER, 2016
10 GLOBAL DRUG INFUSION SYSTEMS MARKET, BY END USER, 2025
11 GLOBAL DRUG INFUSION SYSTEMS MARKET, BY REGION, 2016
12 GLOBAL DRUG INFUSION SYSTEMS MARKET, BY REGION, 2025
13 GLOBAL DRUG INFUSION SYSTEMS MARKET
14 MARKET SHARE ANALYSIS
15 ADVANTAGES OF DRUG INFUSION SYSTEMS
16 DESIRABLE CHARACTERISTICS OF DRUG INFUSION SYSTEMS
17 GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE & GROWTH POTENTIAL, BY PRODUCT TYPE
18 GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE & GROWTH POTENTIAL, BY END USER
19 GLOBAL DRUG INFUSION SYSTEMS MARKET SIZE & GROWTH POTENTIAL, BY APPLICATION
20 NUMBER OF PEOPLE WITH CHRONIC CONDITIONS (U.S.) IN MILLION
21 INFUSION PUMP RECALLS, 2010-2017
22 PER DAY COST SAVINGS VS. HOSPITALS
23 SHARE OF DIFFERENT STRATEGIES
24 PORTER'S FIVE FORCES ANALYSIS
25 MARKET SHARE ANALYSIS
26 COMPONENTS OF DRUG INFUSION SYSTEMS
27 GLOBAL DRUG INFUSION SYSTEMS MARKET, BY COMPONENTS
28 SEGMENTATION OF GLOBAL DRUG INFUSION SYSTEMS MARKET, BY PRODUCT
29 GLOBAL DRUG INFUSION SYSTEMS MARKET, BY PRODUCT, 2016-2025 ($MILLION)
30 GLOBAL LARGE VOLUME INFUSION SYSTEMS MARKET, 2016-2025 ($MILLION)
31 GLOBAL PCA INFUSION SYSTEMS MARKET, 2016-2025 ($MILLION)
32 GLOBAL ELASTOMERIC INFUSION SYSTEMS MARKET, 2016-2025 ($MILLION)
33 GLOBAL INSULIN INFUSION SYSTEMS MARKET, 2016-2025 ($MILLION)
34 GLOBAL SYRINGE INFUSION SYSTEMS MARKET, 2016-2025 ($MILLION)
35 GLOBAL IMPLANTABLE INFUSION SYSTEMS MARKET, 2016-2025 ($MILLION)
36 ADVANTAGES & DISADVANTAGES OF IMPLANTABLE INFUSION SYSTEMS
37 GLOBAL AMBULATORY INFUSION SYSTEMS MARKET, 2016-2025 ($MILLION)
38 GLOBAL ENTERAL INFUSION SYSTEMS MARKET, 2016-2025 ($MILLION)
39 APPLICATIONS OF INFUSION SYSTEMS
40 GLOBAL DRUG INFUSION SYSTEMS MARKET, BY APPLICATION, 2016-2025 ($MILLION)
41 GLOBAL ONCOLOGY INFUSION SYSTEMS MARKET, 2016-2025, ($MILLION)
42 NUMBER OF NEW CANCER CASES
43 TYPES OF DIABETES MELLITUS
44 GLOBAL PATIENTS DIAGNOSED WITH DIABETES
45 GLOBAL DIABETES INFUSION SYSTEMS MARKET, 2016-2025, ($MILLION)
46 GLOBAL ANALGESIA INFUSION SYSTEMS MARKET, 2016-2025, ($MILLION)
47 MOST COMMON TYPES OF CHRONIC PAIN
48 GLOBAL NUTRITION INFUSION SYSTEMS MARKET, 2016-2025, ($MILLION)
49 GLOBAL HAEMATOLOGY INFUSION SYSTEMS MARKET, 2016-2025, ($MILLION)
50 GLOBAL PAEDIATRICS INFUSION SYSTEMS MARKET, 2016-2025, ($MILLION)
51 GLOBAL OTHERS INFUSION SYSTEMS MARKET, 2016-2025, ($MILLION)
52 GLOBAL DRUG INFUSION SYSTEMS MARKET, END USER
53 GLOBAL DRUG INFUSION SYSTEMS MARKET, BY END USER, 2016-2025 ($MILLION)
54 GLOBAL DRUG INFUSION SYSTEMS MARKET, BY REGION, 2016-2025 ($MILLION)
55 NORTH AMERICA DRUG INFUSION SYSTEMS MARKET 2016-2025 ($MILLION)
56 NORTH AMERICA DRUG INFUSION SYSTEMS MARKET, BY COMPONENTS 2016-2025 ($MILLION)
57 THE U.S. DRUG INFUSION SYSTEMS MARKET, BY VALUE, 2016-2025 ($MILLION)
58 THE U.S. DRUG INFUSION SYSTEMS MARKET, BY TYPE 2016-2025($MILLION)
59 CANADIAN DRUG INFUSION SYSTEMS MARKET, BY VALUE, 2016-2025 ($MILLION)
60 CANADIAN DRUG INFUSION PUMPS MARKET, BY TYPE 2016-2025($MILLION)
61 EUROPEAN DRUG INFUSION SYSTEMS MARKET,2016-2025 ($MILLION)
62 EUROPEAN DRUG INFUSION SYSTEMS MARKET, BY COMPONENTS, 2016-2025 ($MILLION)
63 AUSTRIA DRUG INFUSION PUMPS MARKET, BY VALUE, 2016-2025 ($MILLION)
64 AUSTRIA DRUG INFUSION PUMPS MARKET, BY TYPE 2016-2025($MILLION)
65 BELARUS DRUG INFUSION SYSTEMS MARKET, BY VALUE, 2016-2025 ($MILLION)
66 BELARUS DRUG INFUSION PUMPS MARKET, BY TYPE 2016-2025($MILLION)
67 BELGIUM DRUG INFUSION SYSTEMS MARKET, BY VALUE, 2016-2025 ($MILLION)
68 BELGIUM DRUG INFUSION SYSTEMS MARKET, BY TYPE 2016-2025
69 DENMARK DRUG INFUSION SYSTEMS MARKET, BY VALUE, 2016-2025 ($MILLION)
70 DENMARK DRUG INFUSION SYSTEMS MARKET, BY TYPE 2016-2025
71 FINLAND DRUG INFUSION SYSTEMS MARKET, BY VALUE, 2016-2025 ($MILLION)
72 FINLAND DRUG INFUSION SYSTEMS MARKET, BY TYPE 2016-2025 ($MILLION)
73 FRANCE DRUG INFUSION SYSTEMS MARKET, BY VALUE, 2016-2025 ($MILLION)
74 FRANCE DRUG INFUSION PUMPS MARKET, BY VOLUME 2016-2025 ($MILLION)
75 GERMANY DRUG INFUSION PUMPS MARKET, BY VALUE, 2016-2025 ($MILLION)
76 GERMANY DRUG INFUSION PUMPS MARKET, BY TYPE 2016-2025 ($MILLION)
77 GREECE DRUG INFUSION SYSTEMS MARKET, BY VALUE, 2016-2025 ($MILLION)
78 GREECE DRUG INFUSION SYSTEMS MARKET, BY TYPE 2016-2025 ($MILLION)
79 HUNGARY DRUG INFUSION SYSTEMS MARKET, BY VALUE, 2016-2025 ($MILLION)
80 HUNGARY DRUG INFUSION SYSTEMS MARKET, BY TYPE 2016-2025 ($MILLION)
81 IRELAND DRUG INFUSION SYSTEMS MARKET, BY VALUE, 2016-2025 ($MILLION)
82 IRELAND DRUG INFUSION SYSTEMS MARKET, BY TYPE 2016-2025 ($MILLION)
83 ITALY DRUG INFUSION SYSTEMS MARKET, BY VALUE, 2016-2025 ($MILLION)
84 ITALY DRUG INFUSION SYSTEMS MARKET, BY TYPE 2016-2025 ($MILLION)
85 LUXEMBOURG DRUG INFUSION SYSTEMS MARKET, BY VALUE, 2016-2025 ($MILLION)
86 LUXEMBOURG DRUG INFUSION SYSTEMS MARKET, BY TYPE 2016-2025 ($MILLION)
87 NETHERLANDS DRUG INFUSION SYSTEMS MARKET, BY VALUE, 2016-2025 ($MILLION)
88 NETHERLANDS DRUG INFUSION SYSTEMS MARKET, BY TYPE 2016-2025 ($MILLION)
89 NORWAY DRUG INFUSION SYSTEMS MARKET, BY VALUE, 2016-2025 ($MILLION)
90 NORWAY DRUG INFUSION SYSTEMS MARKET, BY TYPE 2016-2025 ($MILLION)
91 POLAND DRUG INFUSION SYSTEMS MARKET, BY VALUE, 2016-2025 ($MILLION)
92 POLAND DRUG INFUSION SYSTEMS MARKET, BY TYPE 2016-2025 ($MILLION)
93 PORTUGAL DRUG INFUSION SYSTEMS MARKET, BY VALUE, 2016-2025 ($MILLION)
94 PORTUGAL DRUG INFUSION SYSTEMS MARKET, BY TYPE 2016-2025 ($MILLION)
95 RUSSIA DRUG INFUSION SYSTEMS MARKET, BY VALUE, 2016-2025 ($MILLION)
96 RUSSIA DRUG INFUSION SYSTEMS MARKET, BY TYPE 2016-2025 ($MILLION)
97 SPAIN DRUG INFUSION SYSTEMS MARKET, BY VALUE, 2016-2025 ($MILLION)
98 SPAIN DRUG INFUSION SYSTEMS MARKET, BY TYPE 2016-2025 ($MILLION)
99 SWEDEN DRUG INFUSION PUMPS MARKET, BY VALUE, 2016-2025 ($MILLION)
100 SWEDEN DRUG INFUSION PUMPS MARKET, BY TYPE 2016-2025 ($MILLION)
101 SWITZERLAND DRUG INFUSION SYSTEMS MARKET, BY VALUE, 2016-2025 ($MILLION)
102 SWITZERLAND DRUG INFUSION SYSTEMS MARKET, BY TYPE 2016-2025 ($MILLION)
103 TURKEY DRUG INFUSION SYSTEMS MARKET, BY VALUE, 2016-2025 ($MILLION)
104 TURKEY DRUG INFUSION SYSTEMS MARKET, BY TYPE 2016-2025 ($MILLION)
105 UKRAINE DRUG INFUSION SYSTEMS MARKET, BY VALUE, 2016-2025 ($MILLION)
106 UKRAINE DRUG INFUSION SYSTEMS MARKET, BY TYPE 2016-2025 ($MILLION)
107 THE U.K. DRUG INFUSION SYSTEMS MARKET, BY VALUE, 2016-2025 ($MILLION)
108 THE U.K. DRUG INFUSION SYSTEMS MARKET, BY TYPE 2016-2025 ($MILLION)
109 ASIA PACIFIC DRUG INFUSION SYSTEMS MARKET, 2016-2025, ($MILLION)
110 ASIA PACIFIC DRUG INFUSION SYSTEMS MARKET, BY COMPONENT, 2016-2025 ($MILLION)
111 AUSTRALIAN DRUG INFUSION SYSTEMS MARKET, BY VALUE, 2016-2025 ($MILLION)
112 AUSTRALIAN DRUG INFUSION SYSTEMS MARKET, BY TYPE 2016-2025 ($MILLION)
113 ASIA PACIFIC DRUG INFUSION SYSTEMS MARKET, BY COMPONENT, 2016-2025 ($MILLION)
114 AUSTRALIAN DRUG INFUSION SYSTEMS MARKET, BY VALUE, 2016-2025 ($MILLION)
115 AUSTRALIAN DRUG INFUSION SYSTEMS MARKET, BY TYPE 2016-2025 ($MILLION)
116 BANGLADESH DRUG INFUSION SYSTEMS MARKET, BY VALUE, 2016-2025 ($MILLION)
117 BANGLADESH DRUG INFUSION PUMPS MARKET, BY TYPE 2016-2025 ($MILLION)
118 CHINA DRUG INFUSION PUMPS MARKET, BY VALUE, 2016-2025 ($MILLION)
119 CHINA DRUG INFUSION SYSTEMS MARKET, BY TYPE 2016-2025 ($MILLION)
120 HONG KONG DRUG INFUSION SYSTEMS MARKET, BY VALUE, 2016-2025 ($MILLION)
121 HONG KONG DRUG INFUSION SYSTEMS MARKET, BY TYPE 2016-2025 ($MILLION)
122 INDIA DRUG INFUSION SYSTEMS MARKET, BY VALUE, 2016-2025 ($MILLION)
123 INDIA DRUG INFUSION SYSTEMS MARKET, BY TYPE 2016-2025 ($MILLION)
124 INDONESIA DRUG INFUSION SYSTEMS MARKET, BY VALUE, 2016-2025 ($MILLION)
125 INDONESIA DRUG INFUSION SYSTEMS MARKET, BY TYPE 2016-2025 ($MILLION)
126 JAPAN DRUG INFUSION PUMPS MARKET, BY VALUE, 2016-2025 ($MILLION)
127 JAPAN DRUG INFUSION SYSTEMS MARKET, BY TYPE 2016-2025($MILLION)
128 SOUTH KOREA DRUG INFUSION PUMPS MARKET, BY VALUE, 2016-2025 ($MILLION)
129 SOUTH KOREA DRUG INFUSION SYSTEMS MARKET, BY TYPE 2016-2025 ($MILLION)
130 MALAYSIA DRUG INFUSION SYSTEMS MARKET, BY VALUE, 2016-2025 ($MILLION)
131 MALAYSIA DRUG INFUSION SYSTEMS MARKET, BY TYPE 2016-2025 ($MILLION)
132 NEW ZEALAND DRUG INFUSION SYSTEMS MARKET, BY VALUE, 2016-2025 ($MILLION)
133 NEW ZEALAND DRUG INFUSION SYSTEMS MARKET, BY TYPE 2016-2025 ($MILLION)
134 PAKISTAN DRUG INFUSION SYSTEMS MARKET, BY VALUE, 2016-2025 ($MILLION)
135 PAKISTAN DRUG INFUSION SYSTEMS MARKET, BY TYPE 2016-2025 ($MILLION)
136 PHILIPPINES DRUG INFUSION SYSTEMS MARKET, BY VALUE, 2016-2025 ($MILLION)
137 PHILIPPINES DRUG INFUSION SYSTEMS MARKET, BY TYPE 2016-2025 ($MILLION)
138 SINGAPORE DRUG INFUSION SYSTEMS MARKET, BY VALUE, 2016-2025 ($MILLION)
139 SINGAPORE DRUG INFUSION SYSTEMS MARKET, BY TYPE 2016-2025 ($MILLION)
140 TAIWAN DRUG INFUSION SYSTEMS MARKET, BY VALUE, 2016-2025 ($MILLION)
141 TAIWAN DRUG INFUSION SYSTEMS MARKET, BY TYPE 2016-2025 ($MILLION)
142 THAILAND DRUG INFUSION SYSTEMS MARKET, BY VALUE, 2016-2025 ($MILLION)
143 THAILAND DRUG INFUSION SYSTEMS MARKET, BY TYPE 2016-2025 ($MILLION)
144 VIETNAM DRUG INFUSION SYSTEMS MARKET, BY VALUE, 2016-2025 ($MILLION)
145 VIETNAM DRUG INFUSION SYSTEMS MARKET, BY TYPE 2016-2025 ($MILLION)
146 LATIN AMERICA DRUG INFUSION SYSTEMS MARKET, 2016-2025 ($MILLION)
147 LATIN AMERICA DRUG INFUSION SYSTEMS MARKET, BY COMPONENTS 2016-2025 ($MILLION)
148 ARGENTINA DRUG INFUSION PUMPS MARKET, BY VALUE, 2016-2025 ($MILLION)
149 ARGENTINA DRUG INFUSION PUMPS MARKET, BY TYPE 2016-2025 ($MILLION)
150 BRAZIL DRUG INFUSION SYSTEMS MARKET, BY VALUE, 2016-2025 ($MILLION)
151 BRAZIL DRUG INFUSION SYSTEMS MARKET, BY TYPE 2016-2025 ($MILLION)
152 CHILE DRUG INFUSION SYSTEMS MARKET, BY VALUE, 2016-2025 ($MILLION)
153 CHILE DRUG INFUSION PUMPS MARKET, BY TYPE 2016-2025 ($MILLION)
154 COLOMBIA DRUG INFUSION SYSTEMS MARKET, BY VALUE, 2016-2025 ($MILLION)
155 COLOMBIA DRUG INFUSION SYSTEMS MARKET, BY TYPE 2016-2025 ($MILLION)
156 MEXICO DRUG INFUSION SYSTEMS MARKET, BY VALUE, 2016-2025 ($MILLION)
157 MEXICO DRUG INFUSION SYSTEMS MARKET, BY TYPE 2016-2025 ($MILLION)
158 MEA DRUG INFUSION SYSTEMS MARKET, 2016-2025 ($MILLION)
159 MEA DRUG INFUSION SYSTEMS MARKET, BY COMPONENT 2016-2025 ($MILLION)
160 EGYPT DRUG INFUSION SYSTEMS MARKET, BY VALUE, 2016-2025 ($MILLION)
161 EGYPT DRUG INFUSION SYSTEMS MARKET, BY TYPE, 2016-2025 ($MILLION)
162 IRAN DRUG INFUSION PUMPS MARKET, BY VALUE, 2016-2025 ($MILLION)
163 IRAN DRUG INFUSION PUMPS MARKET, BY TYPE, 2016-2025 ($MILLION)
164 ISRAEL DRUG INFUSION SYSTEMS MARKET, BY VALUE, 2016-2025 ($MILLION)
165 ISRAEL DRUG INFUSION SYSTEMS MARKET, BY TYPE 2016-2025
166 KENYA DRUG INFUSION SYSTEMS MARKET, BY VALUE, 2016-2025 ($MILLION)
167 KENYA DRUG INFUSION SYSTEMS MARKET, BY TYPE, 2016-2025 ($MILLION)
168 KUWAIT DRUG INFUSION SYSTEMS MARKET, BY VALUE, 2016-2025 ($MILLION)
169 KUWAIT DRUG INFUSION SYSTEMS MARKET, BY TYPE 2016-2025 ($MILLION)
170 NIGERIA DRUG INFUSION SYSTEMS MARKET, BY VALUE, 2016-2025 ($MILLION)
171 NIGERIA DRUG INFUSION PUMPS MARKET, BY TYPE, 2016-2025 ($MILLION)
172 OMAN DRUG INFUSION SYSTEMS MARKET, BY VALUE, 2016-2025 ($MILLION)
173 OMAN DRUG INFUSION SYSTEMS MARKET, BY TYPE, 2016-2025 ($MILLION)
174 QATAR DRUG INFUSION SYSTEMS MARKET, BY VALUE, 2016-2025 ($MILLION)
175 QATAR DRUG INFUSION SYSTEMS MARKET, BY TYPE 2016-2025 ($MILLION)
176 SAUDI ARABIA DRUG INFUSION SYSTEMS MARKET, BY VALUE, 2016-2025 ($MILLION)
177 SAUDI ARABIA DRUG INFUSION SYSTEMS MARKET, BY TYPE 2016-2025 ($MILLION)
178 SOUTH AFRICA DRUG INFUSION PUMPS MARKET, BY VALUE, 2016-2025 ($MILLION)
179 SOUTH AFRICA DRUG INFUSION SYSTEMS MARKET, BY TYPE 2016-2025 ($MILLION)
180 UNITED ARAB EMIRATES DRUG INFUSION SYSTEMS MARKET, BY VALUE, 2016-2025 ($MILLION)
181 UNITED ARAB EMIRATES DRUG INFUSION PUMPS MARKET, BY TYPE 2016-2025 ($MILLION)
182 ARCOMED AG: OVERALL PRODUCT PORTFOLIO
183 ARCOMED AG: PRODUCT PORTFOLIO OF DRUG INFUSION SYSTEMS
184 ARCOMED AG: SWOT ANALYSIS
185 B.BRAUN MELSUNGEN AG: OVERALL PRODUCT PORTFOLIO
186 B.BRAUN MELSUNGEN AG: PRODUCT PORTFOLIO OF DRUG INFUSION SYSTEMS
187 B. BRAUN MELSUNGEN AG: OVERALL FINANCIALS (2014-2016)
188 B. BRAUN MELSUNGEN AG: NET REVENUE BY REGION (2014-2016)
189 B. BRAUN MELSUNGEN AG: REVENUE BY DIVISION (2014-2016)
190 B.BRAUN MELSUNGEN AG:GLOBAL PRESENCE
191 B. BRAUN MELSUNGEN AG: SWOT ANALYSIS
192 BAXTER INTERNATIONAL INC.: OVERALL PRODUCT PORTFOLIO
193 BAXTER INTERNATIONAL INC. : PRODUCT PORTFOLIO OF DRUG INFUSION SYSTEMS
194 BAXTER INTERNATIONAL INC.: OVERALL FINANCIALS (2014-2016)
195 BAXTER INTERNATIONAL INC.: NET REVENUE BY REGION (2014-2016)
196 BAXTER INTERNATIONAL INC.: REVENUE BY SEGMENT (2014-2016)
197 BAXTER INTERNATIONAL INC.: REVENUE BY HOSPITAL PRODUCTS SUB-SEGMENT (2014-2016)
198 BAXTER INTERNATIONAL INC: GLOBAL PRESENCE
199 BAXTER INTERNATIONAL INC.: SWOT ANALYSIS
200 BECTON, DICKINSON AND COMPANY: OVERALL PRODUCT PORTFOLIO
201 BECTON, DICKINSON AND COMPANY: OVERALL FINANCIALS (2015-2017)
202 BECTON, DICKINSON AND COMPANY: NET REVENUE BY REGION (2015-2017)
203 BECTON, DICKINSON AND COMPANY: REVENUE BY BUSINESS SEGMENT (2015-2017)
204 BECTON, DICKINSON AND COMPANY: REVENUE BY SUB-SEGMENT (2015-2017)
205 BECTON, DICKINSON AND COMPANY: GLOBAL PRESENCE
206 BECTON, DICKINSON AND COMPANY: SWOT ANALYSIS
207 CAESAREA MEDICAL ELECTRONICS LTD.: OVERALL PRODUCT PORTFOLIO
208 CAESAREA MEDICAL ELECTRONICS LTD.: PRODUCT PORTFOLIO
209 CAESAREA MEDICAL ELECTRONICS LTD.: SWOT ANALYSIS
210 DEBIOTECH S.A.: OVERALL PRODUCT PORTFOLIO
211 PRODUCT PORTFOLIO FOR DEBIOTECH TECHNOLOGIES SEGMENT
212 DEBIOTECH S.A.: SWOT ANALYSIS
213 FLOWONIX MEDICAL INC.: OVERALL PRODUCT PORTFOLIO
214 FLOWONIX MEDICAL INC.: DRUG INFUSION SYSTEMS PRODUCT PORTFOLIO
215 FLOWONIX MEDICAL INC.: SWOT ANALYSIS
216 FRESENIUS SE & CO. KGAA: OVERALL PRODUCT PORTFOLIO
217 PRODUCT PORTFOLIO FOR FRESENIUS KABI
218 FRESENIUS SE & CO. KGAA: OVERALL FINANCIALS (2014-2016)
219 FRESENIUS KABI: REVENUE BY REGION (2014-2016)
220 FRESENIUS SE & CO. KGAA: REVENUE BY SEGMENT (2014-2016)
221 FRESENIUS SE & CO. KGAA: REVENUE BY SUB-SEGMENT (2014-2016)
222 FRESENIUS SE & CO. KGAA: GLOBAL PRESENCE
223 FRESENIUS SE & CO. KGAA: SWOT ANALYSIS
224 HALYARD HEALTH, INC.: OVERALL PRODUCT PORTFOLIO
225 HALYARD HEALTH, INC.: DRUG INFUSION SYSTEMS PRODUCT PORTFOLIO
226 HALYARD HEALTH, INC.: OVERALL FINANCIALS (2014-2016)
227 HALYARD HEALTH, INC.: REVENUE BY REGION (2015-2017)
228 HALYARD HEALTH, INC.: REVENUE BY BUSINESS SEGMENT (2015-2017)
229 HALYARD HEALTH, INC.: GLOBAL PRESENCE
230 HALYARD HEALTH, INC.: SWOT ANALYSIS
231 ICU MEDICAL INC.: OVERALL PRODUCT PORTFOLIO
232 ICU MEDICAL INC.: PRODUCT PORTFOLIO OF DRUG INFUSION SYSTEMS
233 ICU MEDICAL INC.: OVERALL FINANCIALS (2014-2016)
234 ICU MEDICAL INC.: REVENUE BY SEGMENT (2014-2016)
235 ICU MEDICAL INC.: REVENUE BY SUB-SEGMENT (2014-2016)
236 ICU MEDICAL INC.: GLOBAL PRESENCE
237 ICU MEDICAL INC.: SWOT ANALYSIS
238 IRADIMED CORPORATION: PRODUCT PORTFOLIO OF DRUG INFUSION SYSTEMS
239 IRADIMED CORPORATION: OVERALL FINANCIALS (2014-2016)
240 IRADIMED CORPORATION: REVENUE BY REGION (2014-2016)
241 IRADIMED CORPORATION: REVENUE BY BUSINESS SEGMENT (2015-2017)
242 IRADIMED CORPORATION: GLOBAL PRESENCE
243 IRADIMED CORPORATION:SWOT ANALYSIS
244 INSULET CORPORATION: OVERALL PRODUCT PORTFOLIO
245 INSULET CORPORATION: PRODUCT PORTFOLIO OF DRUG INFUSION SYSTEMS
246 INSULET CORPORATION: OVERALL FINANCIALS (2014-2016)
247 INSULET CORPORATION: REVENUE BY REGION (2014-2016)
248 INSULET CORPORATION: REVENUE BY BUSINESS SEGMENT (2014-2016)
249 INSULET CORPORATION: GLOBAL PRESENCE
250 INSULET CORPORATION: SWOT ANALYSIS
251 MEDTRONIC PUBLIC LIMITED COMPANY: OVERALL PRODUCT PORTFOLIO
252 MEDTRONIC PUBLIC LIMITED COMPANY: PRODUCT PORTFOLIO OF DRUG INFUSION SYSTEMS
253 MEDTRONIC PUBLIC LIMITED COMPANY: OVERALL FINANCIALS (2015-2017)
254 MEDTRONIC PUBLIC LIMITED COMPANY: NET REVENUE BY REGION (2015-2017)
255 MEDTRONIC PUBLIC LIMITED COMPANY: REVENUE BY BUSINESS SEGMENT (2015-2017)
256 MEDTRONIC PUBLIC LIMITED COMPANY: REVENUE BY SUB-SEGMENT (2015-2017)
257 MEDTRONIC PUBLIC LIMITED COMPANY: GLOBAL PRESENCE
258 MEDTRONIC PUBLIC LIMITED COMPANY: SWOT ANALYSIS
259 MOOG, INC.: OVERALL PRODUCT PORTFOLIO
260 MOOG, INC.: PRODUCT PORTFOLIO OF DRUG INFUSION SYSTEMS
261 MOOG, INC.: OVERALL FINANCIALS (2015-2017)
262 MOOG, INC.: REVENUE BY SEGMENT (2015-2017)
263 MOOG, INC.: GLOBAL PRESENCE
264 MOOG, INC. SWOT ANALYSIS
265 SMITHS GROUP PLC: OVERALL PRODUCT PORTFOLIO
266 SMITHS GROUP PLC: PRODUCT PORTFOLIO OF DRUG INFUSION SYSTEMS
267 SMITHS GROUP PLC: OVERALL FINANCIALS (2015-2017)
268 SMITHS GROUP PLC: NET REVENUE BY REGION (2015-2016)
269 SMITHS GROUP PLC: NET REVENUE BY REGION, 2017
270 SMITHS GROUP PLC: REVENUE BY DIVISION (2015-2017)
271 SMITHS GROUP PLC.: REVENUE BY SMITHS MEDICAL SUB-DIVISION (2015-2017)
272 SMITHS GROUP PLC.: GLOBAL PRESENCE
273 SMITHS GROUP PLC SWOT ANALYSIS
274 TANDEM DIABETES CARE, INC.: OVERALL PRODUCT PORTFOLIO
275 TANDEM DIABETES CARE, INC.: PRODUCTS UNDER DEVELOPMENT
276 TANDEM DIABETES CARE: OVERALL FINANCIALS (2014-2016)
277 TANDEM DIABETES CARE: GLOBAL PRESENCE
278 TANDEM DIABETES CARE, INC.: SWOT ANALYSIS
279 TERUMO CORPORATION: OVERALL PRODUCT PORTFOLIO
280 TERUMO CORPORATION: PRODUCT PORTFOLIO OF DRUG INFUSION SYSTEMS
281 TERUMO CORPORATION: OVERALL FINANCIALS (2015-2017)
282 TERUMO CORPORATION: NET REVENUE BY REGION (2015-2017)
283 TERUMO CORPORATION: REVENUE BY BUSINESS SEGMENT (2015-2017)
284 TERUMO CORPORATION: REVENUE BY SUB-SEGMENT (2015-2017)
285 TERUMO CORPORATION: GLOBAL PRESENCE
286 TERUMO CORPORATION: SWOT ANALYSIS
287 ZYNO MEDICAL, LLC: OVERALL PRODUCT PORTFOLIO
288 ZYNO MEDICAL, LLC: PRODUCT PORTFOLIO OF DRUG INFUSION SYSTEMS
289 ZYNO MEDICAL, LLC: SWOT ANALYSIS
290 GLOBAL INFUSION SYSTEMS MARKET SEGMENTATION
291 DATA TRIANGULATION
